Quartz
์ค๋
์ฐ์
/๊ธฐ์
Coinbase CEO's anti-aging startup NewLimit is raising $435 million, tripling its valuation
The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year
๐บ๐ธ ๋ฏธ๊ตญ ยท Quartz ยท "PROGRAM" ยท ์ด 8๊ฑด
ํํฐ ๋ณด๊ธฐํ์ฌ ์ง์
50.0
0 = ๋ถ์ ์ฐ์ธ
50 = ์ค๋ฆฝ
100 = ๊ธ์ ์ฐ์ธ
์ต๊ทผ 7์ผ ๊ธฐ์ค 222๊ฑด์ ๋ถ์ํ ๊ฒฐ๊ณผ, ๋ด์ค ์ฌ๋ฆฌ์ง์๋ 50.0(๊ท ํ)์ ๋๋ค. ๊ธ์ 0๊ฑด(0.0%)ยท์ค๋ฆฝ 222๊ฑด(100.0%)ยท๋ถ์ 0๊ฑด(0.0%)์ด๋ฉฐ, ์ค๋ฆฝ ๋น์ค์ด ๋๋ ทํ๊ฒ ๋์ต๋๋ค. ์ฑํฅ ์ง์๋ ์ข ํฉ 0.0(์ค๋ ๊ท ํ)์ ๋๋ค.
The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year
The Services Track and Partner Hub formalize a $100 million program as Anthropic moves toward an IPO
Workers can now pause data collection for 30 minutes at a time, and some will be allowed to opt out altogether
The company said partners using its Claude Mythos Preview model have already found more than 10,000 high or critical security flaws
Berkshire Hathaway is putting in $10 billion through a private placement, with the rest coming from underwritten offerings and an at-the-market program
ENISA will join Project Glasswing, Anthropic's program for testing the powerful vulnerability-finding model before a wider release
The ride-hailing company is partnering with Israeli AI startup Autobrains and chipmaker Nvidia to deploy autonomous vehicles in Germany, pending regulatory approval
The U.S. pharma giant will pay $650 million upfront to China's Innovent Biologics to co-develop 12 early-stage oncology programs